|
시장보고서
상품코드
2032538
정형외과용 생체 재료 시장 보고서 : 소재별, 용도별, 지역별(2026-2034년)Orthopedic Biomaterials Market Report by Material Type, Application, and Region 2026-2034 |
||||||
세계의 정형외과용 생체 재료 시장 규모는 2025년에 214억 달러에 이르렀습니다. 향후 IMARC Group은 2026-2034년 CAGR 8.16%로 성장을 지속하여, 2034년까지 443억 달러에 이를 것으로 예측했습니다. 고령화 진행, 제품의 급속한 혁신, 의료 산업의 괄목할만한 성장, 다양한 정부 정책의 시행, 광범위한 연구개발(R&:D) 활동 등이 시장을 주도하는 주요 요인으로 작용하고 있습니다.
정형외과용 생체 재료는 손상된 뼈나 관절 조직을 대체하거나 복구하기 위해 정형외과 수술에 사용되는 물질을 말합니다. 이들은 뼈와 관절 조직의 특성을 모방하도록 설계된 합성 또는 천연 물질입니다. 세라믹과 생체활성 유리, 고분자, 인산칼슘 시멘트, 금속, 복합재료 등이 일반적인 재료의 유형입니다. 정형외과용 생체 재료는 고관절, 무릎관절, 어깨관절 치환술, 골절 고정술, 척추 임플란트, 뼈 이식, 연부조직 수복 등 관절 치환술에 널리 사용되고 있습니다. 고강도, 연성, 파괴 인성, 경도, 내식성, 성형성 및 생체 적합성을 갖추고 있습니다.
정형외과용 생체 재료 시장 동향 :
세계적으로 고령화가 진행되면서 골관절염, 골다공증, 골절 등 다양한 근골격계 질환의 위험에 노출되기 쉬운 인구가 증가하고 있는 것이 시장 성장을 가속하는 주요 요인 중 하나입니다. 이에 따라 스포츠 장애, 퇴행성 관절 질환, 외상성 골절 등 정형외과적 질환 및 부상의 유병률이 증가하면서 시장 성장을 견인하고 있습니다. 또한, 정형외과 질환에 대한 인식 증가와 첨단 치료법의 보급도 시장 성장을 가속하는 요인으로 작용하고 있습니다. 여기에 생체 적합성, 내구성, 기계적 강도 및 생체 조직과의 통합성을 향상시켜 정형외과용 임플란트의 성공률과 내구성을 높이는 첨단 생체 재료의 도입이 시장 성장에 탄력을 받고 있습니다. 또한, 천연 유래 생분해성 소재가 조직의 재생과 치유를 촉진하기 위해 정형외과 분야에서 활용되고 있는 것도 시장 성장에 기여하고 있습니다. 또한, 절개 부위 축소, 빠른 회복, 통증 감소, 입원 기간 단축 등의 장점으로 인해 최소침습(MI) 수술에 대한 수요가 증가하고 있는 것도 시장 성장에 긍정적인 영향을 미치고 있습니다. 이 외에도 소비자의 구매력 향상, 활발한 연구개발(R&:D) 활동, 의료 인프라 및 서비스에 대한 투자 확대, 의료진과 환자가 정형외과용 생체 재료 및 치료법을 선택할 수 있도록 장려하는 다양한 정부 정책 시행 등이 시장 성장을 뒷받침하고 있습니다.
본 보고서에서 답변을 얻을 수 있는 주요 질문
- 세계 정형외과용 생체 재료 시장은 지금까지 어떤 추세를 보여 왔으며, 향후 몇 년 동안 어떤 추세를 보일 것인가?
- 세계 정형외과용 생체 재료 시장 성장 촉진요인, 억제요인 및 기회는 무엇인가?
- 각 촉진요인, 제약 요인 및 기회는 세계 정형외과용 생체 재료 시장에 어떤 영향을 미치고 있는가?
- 주요 지역 시장은?
- 가장 매력적인 정형외과용 생체 재료 시장을 가진 국가는?
- 소재 유형별 시장 현황은?
- 정형외과용 생체 재료 시장에서 가장 매력적인 재료의 유형은?
- 용도별 시장 현황은?
- 정형외과용 생체 재료 시장에서 가장 매력적인 용도는?
- 세계 정형외과용 생체 재료 시장 경쟁 구도는 어떤가?
- 세계 정형외과용 생체 재료 시장의 주요 기업은?
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 주요 요약
제4장 서론
제5장 세계의 정형외과용 생체 재료 시장
제6장 시장 분석 : 소재 유형별
제7장 시장 분석 : 용도별
제8장 시장 분석 : 지역별
제9장 촉진, 억제 및 기회
제10장 밸류체인 분석
제11장 Porter's Five Forces 분석
제12장 가격 분석
제13장 경쟁 구도
JHS 26.05.18The global orthopedic biomaterials market size reached USD 21.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 44.3 Billion by 2034, exhibiting a growth rate (CAGR) of 8.16% during 2026-2034. The rising geriatric population, rapid product innovations, significant growth in the healthcare industry, the implementation of various government initiatives, and extensive research and development (R&D) activities are some of the key factors driving the market.
Orthopedic biomaterials are substances used in orthopedic surgery to replace or repair damaged bone or joint tissues. They are either synthetic or natural and are designed to mimic the properties of bone and joint tissues. Ceramics and bioactive glasses, polymers, calcium phosphate cement, metal, and composites are some of the common types of materials. Orthopedic biomaterials are widely used for joint replacement surgeries, such as hip, knee, and shoulder replacements, fracture fixations, spinal implants, bone grafting, and soft tissue repair. They exhibit high strength, ductility, fracture toughness, hardness, corrosion resistance, formability, and biocompatibility.
ORTHOPEDIC BIOMATERIALS MARKET TRENDS:
The rising geriatric population across the globe prone to the risk of various musculoskeletal disorders, such as osteoarthritis, osteoporosis, and fractures is one of the key factors propelling the market growth. In line with this, the increasing prevalence of orthopedic conditions and injuries, such as sports injuries, degenerative joint diseases, and traumatic fractures, is favoring the market growth. Moreover, the growing awareness about orthopedic disorders and the availability of advanced treatment solutions is acting as another growth-inducing factor. Apart from this, the introduction of advanced biomaterials that offer enhanced biocompatibility, durability, mechanical strength, and integration with natural tissues, improving the success rates and longevity of orthopedic implants, is providing an impetus to the market growth. Additionally, the utilization of biodegradable materials that are derived from natural sources and are used in orthopedics to promote tissue regeneration and healing is contributing to the market growth. Furthermore, the increasing demand for minimally invasive (MI) surgeries due to their advantages, such as smaller incisions, faster recovery, reduced pain, and shorter hospital stays, is positively impacting the market growth. Other factors, including rising expenditure capacities of consumers, extensive research and development (R&D) activities, growing investments in healthcare infrastructure and services, and the implementation of various government initiatives that encourage healthcare providers and patients to opt for orthopedic biomaterials and procedures, are supporting the market growth.
KEY MARKET SEGMENTATION:
Material Type Insights:
- Ceramics and Bioactive Glasses
- Polymers
- Calcium Phosphate Cement
- Metal
- Composites
Application Insights:
- Orthopedic Implants
- Joint Replacement/Reconstruction
- Orthobiologics
- Viscosupplementation
- Bio-Resorbable Tissue Fixation
Regional Insights:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for orthopedic biomaterials. Some of the factors driving the North America orthopedic biomaterials market included the rising geriatric population, various technological advancements, and growing expenditure capacities of consumers.
COMPETITIVE LANDSCAPE:
The report has also provided a comprehensive analysis of the competitive landscape in the global orthopedic biomaterials market. Detailed profiles of all major companies have been provided. Some of the companies covered include Arthrex Inc., Berkeley Advanced Biomaterials, CAM Bioceramics B.V., Collagen Matrix Inc., CoorsTek Inc., Evonik Industries AG (RAG-Stiftung), Exactech Inc., Globus Medical Inc., Invibio Ltd. (Victrex plc), Koninklijke DSM N.V., Medical Devices Business Services Inc., Stryker Corporation, Zimmer Biomet, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
KEY QUESTIONS ANSWERED IN THIS REPORT
- How has the global orthopedic biomaterials market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global orthopedic biomaterials market?
- What is the impact of each driver, restraint, and opportunity on the global orthopedic biomaterials market?
- What are the key regional markets?
- Which countries represent the most attractive orthopedic biomaterials market?
- What is the breakup of the market based on the material type?
- Which is the most attractive material type in the orthopedic biomaterials market?
- What is the breakup of the market based on the application?
- Which is the most attractive application in the orthopedic biomaterials market?
- What is the competitive structure of the global orthopedic biomaterials market?
- Who are the key players/companies in the global orthopedic biomaterials market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Orthopedic Biomaterials Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Material Type
- 6.1 Ceramics and Bioactive Glasses
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Polymers
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Calcium Phosphate Cement
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Metal
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Composites
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
7 Market Breakup by Application
- 7.1 Orthopedic Implants
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Joint Replacement/Reconstruction
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Orthobiologics
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Viscosupplementation
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Bio-Resorbable Tissue Fixation
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by Region
- 8.1 North America
- 8.1.1 United States
- 8.1.1.1 Market Trends
- 8.1.1.2 Market Forecast
- 8.1.2 Canada
- 8.1.2.1 Market Trends
- 8.1.2.2 Market Forecast
- 8.1.1 United States
- 8.2 Asia-Pacific
- 8.2.1 China
- 8.2.1.1 Market Trends
- 8.2.1.2 Market Forecast
- 8.2.2 Japan
- 8.2.2.1 Market Trends
- 8.2.2.2 Market Forecast
- 8.2.3 India
- 8.2.3.1 Market Trends
- 8.2.3.2 Market Forecast
- 8.2.4 South Korea
- 8.2.4.1 Market Trends
- 8.2.4.2 Market Forecast
- 8.2.5 Australia
- 8.2.5.1 Market Trends
- 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
- 8.2.6.1 Market Trends
- 8.2.6.2 Market Forecast
- 8.2.7 Others
- 8.2.7.1 Market Trends
- 8.2.7.2 Market Forecast
- 8.2.1 China
- 8.3 Europe
- 8.3.1 Germany
- 8.3.1.1 Market Trends
- 8.3.1.2 Market Forecast
- 8.3.2 France
- 8.3.2.1 Market Trends
- 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
- 8.3.3.1 Market Trends
- 8.3.3.2 Market Forecast
- 8.3.4 Italy
- 8.3.4.1 Market Trends
- 8.3.4.2 Market Forecast
- 8.3.5 Spain
- 8.3.5.1 Market Trends
- 8.3.5.2 Market Forecast
- 8.3.6 Russia
- 8.3.6.1 Market Trends
- 8.3.6.2 Market Forecast
- 8.3.7 Others
- 8.3.7.1 Market Trends
- 8.3.7.2 Market Forecast
- 8.3.1 Germany
- 8.4 Latin America
- 8.4.1 Brazil
- 8.4.1.1 Market Trends
- 8.4.1.2 Market Forecast
- 8.4.2 Mexico
- 8.4.2.1 Market Trends
- 8.4.2.2 Market Forecast
- 8.4.3 Others
- 8.4.3.1 Market Trends
- 8.4.3.2 Market Forecast
- 8.4.1 Brazil
- 8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast
9 Drivers, Restraints, and Opportunities
- 9.1 Overview
- 9.2 Drivers
- 9.3 Restraints
- 9.4 Opportunities
10 Value Chain Analysis
11 Porters Five Forces Analysis
- 11.1 Overview
- 11.2 Bargaining Power of Buyers
- 11.3 Bargaining Power of Suppliers
- 11.4 Degree of Competition
- 11.5 Threat of New Entrants
- 11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
- 13.1 Market Structure
- 13.2 Key Players
- 13.3 Profiles of Key Players
- 13.3.1 Arthrex Inc.
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.2 Berkeley Advanced Biomaterials
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.3 CAM Bioceramics B.V.
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.4 Collagen Matrix Inc.
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.5 CoorsTek Inc.
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.6 Evonik Industries AG (RAG-Stiftung)
- 13.3.6.1 Company Overview
- 13.3.6.2 Product Portfolio
- 13.3.7 Exactech Inc.
- 13.3.7.1 Company Overview
- 13.3.7.2 Product Portfolio
- 13.3.8 Globus Medical Inc.
- 13.3.8.1 Company Overview
- 13.3.8.2 Product Portfolio
- 13.3.9 Invibio Ltd. (Victrex plc)
- 13.3.9.1 Company Overview
- 13.3.9.2 Product Portfolio
- 13.3.10 Koninklijke DSM N.V.
- 13.3.10.1 Company Overview
- 13.3.10.2 Product Portfolio
- 13.3.11 Medical Devices Business Services Inc.
- 13.3.11.1 Company Overview
- 13.3.11.2 Product Portfolio
- 13.3.12 Stryker Corporation
- 13.3.12.1 Company Overview
- 13.3.12.2 Product Portfolio
- 13.3.13 Zimmer Biomet
- 13.3.13.1 Company Overview
- 13.3.13.2 Product Portfolio
- 13.3.1 Arthrex Inc.
